Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outset Medical (OM) Operating Leases (2020 - 2025)

Outset Medical (OM) has disclosed Operating Leases for 6 consecutive years, with $5.0 million as the latest value for Q4 2025.

  • Quarterly Operating Leases rose 86.66% to $5.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $5.0 million through Dec 2025, up 86.66% year-over-year, with the annual reading at $5.0 million for FY2025, 86.66% up from the prior year.
  • Operating Leases for Q4 2025 was $5.0 million at Outset Medical, up from $1.2 million in the prior quarter.
  • The five-year high for Operating Leases was $7.8 million in Q1 2021, with the low at $1.2 million in Q3 2025.
  • Average Operating Leases over 5 years is $4.9 million, with a median of $5.1 million recorded in 2023.
  • Peak annual rise in Operating Leases hit 86.66% in 2025, while the deepest fall reached 60.6% in 2025.
  • Over 5 years, Operating Leases stood at $6.9 million in 2021, then fell by 19.11% to $5.6 million in 2022, then decreased by 19.62% to $4.5 million in 2023, then plummeted by 40.12% to $2.7 million in 2024, then soared by 86.66% to $5.0 million in 2025.
  • According to Business Quant data, Operating Leases over the past three periods came in at $5.0 million, $1.2 million, and $1.7 million for Q4 2025, Q3 2025, and Q2 2025 respectively.